CytoMed Therapeutics Limited
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update 2023-11-17 22:21
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference 2023-11-14 20:47
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency 2023-08-16 01:00
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology 2023-08-01 19:00
CytoMed Therapeutics to Ring Nasdaq Closing Bell 2023-05-11 21:00
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology 2023-05-09 22:07
CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering 2023-04-14 08:00
1